The CDSCO has issued an advisory requiring GLP-1 weight-loss drugs to be sold only with a prescription. Pharma companies are cautioned against promoting these drugs to the public. The advisory, ...
Draft guidelines aim to align India's medtech software framework with global practices; industry seeks more clarity on AI/ML ...
CDSCO to issue instant NOCs for drug testing from June 1, 2026, speeding up approvals while retaining technical scrutiny at ...
The Central Drugs Standard Control Organization (CDSCO), under the Directorate General of Health Services (DGHS), Government ...
Health and Me on MSN
CDSCO threatens action against pharma companies for promoting GLP-1 weight-loss drugs
The CDSCO mandated that there should be no ads, whether direct or indirect, in print, electronic, digital, social media, or any other public platform intended, directly or indirectly, to promote GLP-1 ...
In a move aimed at speeding up approvals for new drugs, the government has changed the way testing permissions are granted, ...
CDSCO switches application procedure for PAC in marketing authorisation on r-DNA products online: Gireesh Babu, New Delhi Wednesday, March 11, 2026, 08:00 Hrs [IST] The Central Dr ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results